Abbott described the update as "critically important," and the American College of Cardiology expressed relief that some proposed changes did not actually end up happening. 

“Some people have expressed concerns about taking the vaccine,” the AHA wrote. “However, after review by science and medical experts, the association is confident the benefits of vaccination far exceed the very small, rare risks."

The authors examined data from more than 1.2 million patients, tracking individuals who had previously been hospitalized for heart failure and then returned later due to COVID-19. 

Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  

The researchers, sharing their work in the American Journal of Cardiology, suggested multiple reasons why this may be the case. 

Physicians may want to think twice before prescribing certain medications, including drugs for pain or depression, to some female patients, the authors observed. 

The research included data from more than 47,000 hospitalized COVID-19 patients. 

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 

Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.  

The authors found a link between six months of empagliflozin and a reduction in extracellular volume, sharing their findings in JACC: Cardiovascular Imaging.